CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cellsNobuyuki Ishikura, Haruhiko SatoInternational Journal of OncologyJanuary 30, 201510.3892/ijo.2015.2860Cited by 8SaveCiteExport RISWatch citationsRelated PapersAnti‑VEGF antibody triggers the effect of anti‑PD‑L1 antibody in PD‑L1<sup>low</sup>and immune desert‑like mouse tumors|Oncology Reports|2021|19